Inspirna
Oncology Therapeutics · Health Care
2 legal entities
Facts
as of Nov 20, 2026News May 21, 2024 Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D.
- Legal name
- Inspirna, Inc.
- Headquarters
- New York, United States
- Employees
- 17US Form 5500 (plan participants) · Dec 2024
- Legal entities
- 2 in 1 country
- Register numbers
- EIN 273120409
- Official records
- Wikidata Q30288559SEC CIK 1651159
- Website
- inspirna.com
These are the key facts about Inspirna on Alion as of Nov 20, 2026. Inspirna is headquartered in New York, United States. It has raised $133.9M in 4 funding rounds. The latest round is Series D of $55.1M, announced in 2022.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Funding
Full ledger, 4 records →Inspirna has $133.9M paid in by investors, lenders and donors.
$133.9MPaid in
Money innewest first
$55.1MPaid
$6MPaid
$39.8MPaid
1 more record: amounts, dates and sources of every round, loan and commitmentProUnlockor this company alone for 30 days · 50 credits
Money by yearUSD, rounds and grants
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Ownership
All holders and entities →Inspirna operates through 2 legal entities in 1 country.
Legal entities2 in 1 country
Inspirna, Inc.
operator · US EIN 273120409
US
Rgenix, Inc.
related
US
Holders and shares as each register or filing states them.
People
17EmployeesUS Form 5500 (plan participants) · Dec 2024
Products
Products →Inspirna has 3 clinical trials on record, 0 under way.
Clinical trials
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
phase 2 · stopped or withdrawn · 76 participants · Colorectal Cancer; Metastatic Colon Cancer
Oct 2023
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
phase 1 · completed · 89 participants · Gastrointestinal Cancer; Gastrointestinal Neoplasms; Colorectal Cancer; Colorec…
Jun 2018
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
phase 1 · completed · 146 participants · Endometrial Cancer; Endometrial Cancer Recurrent; Lung Cancer Recurrent; Lung C…
Nov 2016
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Risk
Full record →Inspirna in public registers.
Legal entity active
Inspirna, Inc.
Not checked
No match
None
None
Patents
6
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Milestones
Sources: the outlets named on each headline, each story once
Footprint
Hiring in 2 cities in 1 country.
2Cities
1Countries
Loading the map
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| New York United States | Headquarters | 0 | ||
| Long Island City United States | Regional office | 0 |
Source: office addresses in postings and company registers
